Akebia Therapeutics Inc. (AKBA) Stock Price, News & Historical Data (original) (raw)
NewsProfileAnalyst Coverage5 Yr. FinancialsDividendsEarningsPrice HistoryEventsInsiders
Akebia Therapeutics Inc. News
Axovant Plummets On Disappointing Alzheimer's Treatment Data - Biotech Movers
The company said Tuesday its Phase 3 study of intepirdine in patients with Alzheimer's disease did not achieve its co-primary efficacy endpoints.Meanwhile, shares of Genocea Biosciences Inc. were down, after the Cambridge, Mass.-based company announced a shift to immuno-oncology and a focus on developing neoantigen cancer vaccines.